Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
The BioBay Investor Forum selected...
“Venture capital investment in China life science...
Hua Medicine, an innovative drug development and...
Chiva Pharma of China paid $4 million for global rights...
CompanDX, a UK diagnostic startup, raised $6.1 million...
Innovent Biologics, a Suzhou company formed last year, is...
Charles River Labs will pay $27 million to acquire a 75%...
Innovent Biologics, a Suzhou antibody development and...
ShangPharma, one of China’s largest CROs, signed an...
Beckman Coulter Life Sciences, a US lab equipment...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
